(Q37415150)

20 August 2017

Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel (English)

1 reference

20 August 2017

Max Tsai

1

1 reference

20 August 2017

Ze Lu

2

1 reference

20 August 2017

Jie Wang

3

1 reference

20 August 2017

Teng-Kuang Yeh

4

1 reference

20 August 2017

M Guillaume Wientjes

5

1 reference

20 August 2017

Jessie L-S Au

6

1 reference

20 August 2017

20 April 2007

1 reference

20 August 2017

Pharmaceutical Research

1 reference

20 August 2017

24

1 reference

20 August 2017

9

1 reference

20 August 2017

1691-1701

1 reference

describes a project that uses

20 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2774739/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

How can we standardize peritoneal thickness measurements in experimental studies in rats?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Pharmacokinetics of the taxanes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Pharmacologic study of etoposide and cisplatin by the intraperitoneal route.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Formulating paclitaxel in nanoparticles alters its disposition

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Communication between peritoneal cavity and mediastinal lymph nodes demonstrated by Tc-99m albumin nanocolloid intraperitoneal injection.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Absorption of insulin in the peritoneal cavity in a diabetic animal model.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774739

Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching

3 December 2018

1 reference

12 December 2020

Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment

1 reference

12 December 2020

Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy

1 reference

12 December 2020

Nanoparticle albumin-bound paclitaxel for metastatic breast cancer

1 reference

12 December 2020

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

1 reference

12 December 2020

Morphology of the designed biodegradable cisplatin microsphere

1 reference

12 December 2020

Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer

1 reference

12 December 2020

Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally

1 reference

12 December 2020

Whole-body autoradiography

1 reference

12 December 2020

Peritoneal absorption of macromolecules studied by quantitative autoradiography

1 reference

12 December 2020

Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide

1 reference

12 December 2020

Pharmacokinetics of intraperitoneal doxorubicin in combination with systemic cyclophosphamide and cis-platinum in the treatment of stage III ovarian cancer

1 reference

12 December 2020

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study

1 reference

12 December 2020

Hepatic metabolism and biliary excretion of Taxol in rats and humans

1 reference

12 December 2020

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

12 December 2020

10.1007/S11095-007-9298-0

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

17447121

1 reference